Disintegrin and metalloproteinase domain-containing protein 9 is an enzyme that in humans is encoded by the ADAM9 gene.[5][6]
Function
editThis gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Two alternative splice variants have been identified, encoding distinct isoforms.[6]
Interactions
editADAM9 has been shown to interact with:
References
edit- ^ a b c ENSG00000282230 GRCh38: Ensembl release 89: ENSG00000168615, ENSG00000282230 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031555 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Weskamp G, Kratzschmar J, Reid MS, Blobel CP (Jul 1996). "MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains". J Cell Biol. 132 (4): 717–26. doi:10.1083/jcb.132.4.717. PMC 2199860. PMID 8647900.717-26&rft.date=1996-07&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199860#id-name=PMC&rft_id=info:pmid/8647900&rft_id=info:doi/10.1083/jcb.132.4.717&rft.aulast=Weskamp&rft.aufirst=G&rft.au=Kratzschmar, J&rft.au=Reid, MS&rft.au=Blobel, CP&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199860&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- ^ a b "Entrez Gene: ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma)".
- ^ Nelson KK, Schlöndorff J, Blobel CP (Nov 1999). "Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta". Biochem. J. 343 (Pt 3): 673–80. doi:10.1042/0264-6021:3430673. PMC 1220601. PMID 10527948.673-80&rft.date=1999-11&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220601#id-name=PMC&rft_id=info:pmid/10527948&rft_id=info:doi/10.1042/0264-6021:3430673&rft.aulast=Nelson&rft.aufirst=KK&rft.au=Schlöndorff, J&rft.au=Blobel, CP&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220601&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- ^ a b Howard L, Nelson KK, Maciewicz RA, Blobel CP (Oct 1999). "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1". J. Biol. Chem. 274 (44): 31693–9. doi:10.1074/jbc.274.44.31693. PMID 10531379.31693-9&rft.date=1999-10&rft_id=info:doi/10.1074/jbc.274.44.31693&rft_id=info:pmid/10531379&rft.aulast=Howard&rft.aufirst=L&rft.au=Nelson, KK&rft.au=Maciewicz, RA&rft.au=Blobel, CP&rft_id=https://doi.org/10.1074%2Fjbc.274.44.31693&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
Further reading
edit- Mazzocca A, Coppari R, De Franco R, Cho JY, Libermann TA, Pinzani M, Toker A (June 2005). "A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions". Cancer Res. 65 (11): 4728–38. doi:10.1158/0008-5472.CAN-04-4449. PMID 15930291.4728-38&rft.date=2005-06&rft_id=info:doi/10.1158/0008-5472.CAN-04-4449&rft_id=info:pmid/15930291&rft.aulast=Mazzocca&rft.aufirst=A&rft.au=Coppari, R&rft.au=De Franco, R&rft.au=Cho, JY&rft.au=Libermann, TA&rft.au=Pinzani, M&rft.au=Toker, A&rft_id=https://doi.org/10.1158%2F0008-5472.CAN-04-4449&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Nomura N, Miyajima N, Sazuka T, et al. (1995). "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1". DNA Res. 1 (1): 27–35. doi:10.1093/dnares/1.1.27. PMID 7584026.27-35&rft.date=1995&rft_id=info:doi/10.1093/dnares/1.1.27&rft_id=info:pmid/7584026&rft.aulast=Nomura&rft.aufirst=N&rft.au=Miyajima, N&rft.au=Sazuka, T&rft_id=https://doi.org/10.1093%2Fdnares%2F1.1.27&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Nomura N, Miyajima N, Sazuka T, et al. (1995). "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (supplement)". DNA Res. 1 (1): 47–56. doi:10.1093/dnares/1.1.47. PMID 7584028.47-56&rft.date=1995&rft_id=info:doi/10.1093/dnares/1.1.47&rft_id=info:pmid/7584028&rft.aulast=Nomura&rft.aufirst=N&rft.au=Miyajima, N&rft.au=Sazuka, T&rft_id=https://doi.org/10.1093%2Fdnares%2F1.1.47&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- McKie N, Dallas DJ, Edwards T, et al. (1996). "Cloning of a novel membrane-linked metalloproteinase from human myeloma cells". Biochem. J. 318 (2): 459–62. doi:10.1042/bj3180459. PMC 1217643. PMID 8809033.459-62&rft.date=1996&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1217643#id-name=PMC&rft_id=info:pmid/8809033&rft_id=info:doi/10.1042/bj3180459&rft.aulast=McKie&rft.aufirst=N&rft.au=Dallas, DJ&rft.au=Edwards, T&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1217643&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- McKie N, Edwards T, Dallas DJ, et al. (1997). "Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes". Biochem. Biophys. Res. Commun. 230 (2): 335–9. doi:10.1006/bbrc.1996.5957. PMID 9016778.335-9&rft.date=1997&rft_id=info:doi/10.1006/bbrc.1996.5957&rft_id=info:pmid/9016778&rft.aulast=McKie&rft.aufirst=N&rft.au=Edwards, T&rft.au=Dallas, DJ&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Izumi Y, Hirata M, Hasuwa H, et al. (1999). "A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor". EMBO J. 17 (24): 7260–72. doi:10.1093/emboj/17.24.7260. PMC 1171072. PMID 9857183.7260-72&rft.date=1999&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171072#id-name=PMC&rft_id=info:pmid/9857183&rft_id=info:doi/10.1093/emboj/17.24.7260&rft.aulast=Izumi&rft.aufirst=Y&rft.au=Hirata, M&rft.au=Hasuwa, H&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1171072&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Roghani M, Becherer JD, Moss ML, et al. (1999). "Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity". J. Biol. Chem. 274 (6): 3531–40. doi:10.1074/jbc.274.6.3531. PMID 9920899.3531-40&rft.date=1999&rft_id=info:doi/10.1074/jbc.274.6.3531&rft_id=info:pmid/9920899&rft.aulast=Roghani&rft.aufirst=M&rft.au=Becherer, JD&rft.au=Moss, ML&rft_id=https://doi.org/10.1074%2Fjbc.274.6.3531&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Nelson KK, Schlöndorff J, Blobel CP (2000). "Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta". Biochem. J. 343 (3): 673–80. doi:10.1042/0264-6021:3430673. PMC 1220601. PMID 10527948.673-80&rft.date=2000&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220601#id-name=PMC&rft_id=info:pmid/10527948&rft_id=info:doi/10.1042/0264-6021:3430673&rft.aulast=Nelson&rft.aufirst=KK&rft.au=Schlöndorff, J&rft.au=Blobel, CP&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1220601&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Howard L, Nelson KK, Maciewicz RA, Blobel CP (1999). "Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1". J. Biol. Chem. 274 (44): 31693–9. doi:10.1074/jbc.274.44.31693. PMID 10531379.31693-9&rft.date=1999&rft_id=info:doi/10.1074/jbc.274.44.31693&rft_id=info:pmid/10531379&rft.aulast=Howard&rft.aufirst=L&rft.au=Nelson, KK&rft.au=Maciewicz, RA&rft.au=Blobel, CP&rft_id=https://doi.org/10.1074%2Fjbc.274.44.31693&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Zhou M, Graham R, Russell G, Croucher PI (2001). "MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin". Biochem. Biophys. Res. Commun. 280 (2): 574–80. doi:10.1006/bbrc.2000.4155. PMID 11162558.574-80&rft.date=2001&rft_id=info:doi/10.1006/bbrc.2000.4155&rft_id=info:pmid/11162558&rft.aulast=Zhou&rft.aufirst=M&rft.au=Graham, R&rft.au=Russell, G&rft.au=Croucher, PI&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Namba K, Nishio M, Mori K, et al. (2002). "Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes". Cell. Immunol. 213 (2): 104–13. doi:10.1006/cimm.2001.1873. PMID 11831872.104-13&rft.date=2002&rft_id=info:doi/10.1006/cimm.2001.1873&rft_id=info:pmid/11831872&rft.aulast=Namba&rft.aufirst=K&rft.au=Nishio, M&rft.au=Mori, K&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Eto K, Huet C, Tarui T, et al. (2002). "Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions". J. Biol. Chem. 277 (20): 17804–10. doi:10.1074/jbc.M200086200. PMID 11882657.17804-10&rft.date=2002&rft_id=info:doi/10.1074/jbc.M200086200&rft_id=info:pmid/11882657&rft.aulast=Eto&rft.aufirst=K&rft.au=Huet, C&rft.au=Tarui, T&rft_id=https://doi.org/10.1074%2Fjbc.M200086200&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Lim JM, Lee JH, Wee WR, Joo CK (2002). "Downregulated expression of ADAM9 in anterior polar cataracts". Journal of Cataract and Refractive Surgery. 28 (4): 697–702. doi:10.1016/S0886-3350(01)01236-6. PMID 11955914. S2CID 21982654.697-702&rft.date=2002&rft_id=https://api.semanticscholar.org/CorpusID:21982654#id-name=S2CID&rft_id=info:pmid/11955914&rft_id=info:doi/10.1016/S0886-3350(01)01236-6&rft.aulast=Lim&rft.aufirst=JM&rft.au=Lee, JH&rft.au=Wee, WR&rft.au=Joo, CK&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Hotoda N, Koike H, Sasagawa N, Ishiura S (2002). "A secreted form of human ADAM9 has an alpha-secretase activity for APP". Biochem. Biophys. Res. Commun. 293 (2): 800–5. doi:10.1016/S0006-291X(02)00302-9. PMID 12054541.800-5&rft.date=2002&rft_id=info:doi/10.1016/S0006-291X(02)00302-9&rft_id=info:pmid/12054541&rft.aulast=Hotoda&rft.aufirst=N&rft.au=Koike, H&rft.au=Sasagawa, N&rft.au=Ishiura, S&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Amour A, Knight CG, English WR, et al. (2002). "The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs". FEBS Lett. 524 (1–3): 154–8. doi:10.1016/S0014-5793(02)03047-8. PMID 12135759. S2CID 37423323.1–3&rft.pages=154-8&rft.date=2002&rft_id=https://api.semanticscholar.org/CorpusID:37423323#id-name=S2CID&rft_id=info:pmid/12135759&rft_id=info:doi/10.1016/S0014-5793(02)03047-8&rft.aulast=Amour&rft.aufirst=A&rft.au=Knight, CG&rft.au=English, WR&rft_id=https://doi.org/10.1016%2FS0014-5793%2802%2903047-8&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.16899-903&rft.date=2003&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139241#id-name=PMC&rft_id=info:pmid/12477932&rft_id=info:doi/10.1073/pnas.242603899&rft_id=info:bibcode/2002PNAS...9916899M&rft.aulast=Strausberg&rft.aufirst=RL&rft.au=Feingold, EA&rft.au=Grouse, LH&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC139241&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Mohan S, Thompson GR, Amaar YG, et al. (2003). "ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts". Biochemistry. 41 (51): 15394–403. doi:10.1021/bi026458q. PMID 12484779.15394-403&rft.date=2003&rft_id=info:doi/10.1021/bi026458q&rft_id=info:pmid/12484779&rft.aulast=Mohan&rft.aufirst=S&rft.au=Thompson, GR&rft.au=Amaar, YG&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Asai M, Hattori C, Szabó B, et al. (2003). "Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase". Biochem. Biophys. Res. Commun. 301 (1): 231–5. doi:10.1016/S0006-291X(02)02999-6. PMID 12535668.231-5&rft.date=2003&rft_id=info:doi/10.1016/S0006-291X(02)02999-6&rft_id=info:pmid/12535668&rft.aulast=Asai&rft.aufirst=M&rft.au=Hattori, C&rft.au=Szabó, B&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- O'Shea C, McKie N, Buggy Y, et al. (2003). "Expression of ADAM-9 mRNA and protein in human breast cancer". Int. J. Cancer. 105 (6): 754–61. doi:10.1002/ijc.11161. PMID 12767059. S2CID 19284959.754-61&rft.date=2003&rft_id=https://api.semanticscholar.org/CorpusID:19284959#id-name=S2CID&rft_id=info:pmid/12767059&rft_id=info:doi/10.1002/ijc.11161&rft.aulast=O'Shea&rft.aufirst=C&rft.au=McKie, N&rft.au=Buggy, Y&rft_id=https://doi.org/10.1002%2Fijc.11161&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
- Grützmann R, Lüttges J, Sipos B, et al. (2004). "ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma". Br. J. Cancer. 90 (5): 1053–8. doi:10.1038/sj.bjc.6601645. PMC 2409625. PMID 14997207.1053-8&rft.date=2004&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409625#id-name=PMC&rft_id=info:pmid/14997207&rft_id=info:doi/10.1038/sj.bjc.6601645&rft.aulast=Grützmann&rft.aufirst=R&rft.au=Lüttges, J&rft.au=Sipos, B&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409625&rfr_id=info:sid/en.wikipedia.org:ADAM9" class="Z3988">
External links
edit- ADAM9 on the Atlas of Genetics and Oncology
- Human ADAM9 genome location and ADAM9 gene details page in the UCSC Genome Browser.